FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4289939749> ?p ?o ?g. }

• W4289939749 abstract "Epidemiological analyses indicate that type 2 diabetes mellitus (T2DM) is a risk factor for Alzheimer's disease (AD). They share common pathophysiological mechanisms. Thus, it has been increasingly suggested that several anti-T2DM drugs may have therapeutic potential in AD. Exendin-4, as a glucagon-like peptide-1 (GLP-1) receptor agonist, is an approved drug used to treat T2DM. In this research, the neuroprotective effect of Exendin-4 was investigated for the first time using transgenic Caenorhabditis elegans . Our results demonstrated that Exendin-4 attenuated the amyloid-β (1-42) (Aβ1-42) toxicity via multiple mechanisms, such as depressing its expression on protein and mRNA and reducing Aβ (1-42) accumulation. Exendin-4 at 0.5 mg/ml had been shown to extend life by 34.39% in CL4176 and delay the onset of paralysis in CL4176 and CL2006 which were increased by 8.18 and 8.02%, respectively. With the treatment of Exendin-4, the nuclear translocation of DAF-16 in the transgenic nematode TJ356 was enhanced. Superoxide dismutase-3 (SOD-3), as a downstream target gene regulated by DAF-16, was upregulated on mRNA level and activity. The reactive oxygen species (ROS) level was decreased. In contrast, we observed that the ability of Exendin-4 to regulate SOD was decreased in CL4176 worms with the DAF-16 gene silenced. The activity of SOD and the mRNA level of sod-3 were downregulated by 30.45 and 43.13%, respectively. Taken together, Exendin-4 attenuated Aβ (1-42) toxicity in the C. elegans model of AD via decreasing the expression and the accumulation of Aβ (1-42). Exendin-4 exhibited the ability of antioxidant stress through DAF-16. With continuous research, Exendin-4 would become a potential therapeutic strategy for treating AD." @default.
• W4289939749 created "2022-08-06" @default.
• W4289939749 creator A5002194502 @default.
• W4289939749 creator A5009923185 @default.
• W4289939749 creator A5015179224 @default.
• W4289939749 creator A5030633188 @default.
• W4289939749 creator A5032041646 @default.
• W4289939749 creator A5037431238 @default.
• W4289939749 date "2022-08-05" @default.
• W4289939749 modified "2023-09-26" @default.
• W4289939749 title "Exendin-4 alleviates β-Amyloid peptide toxicity via DAF-16 in a Caenorhabditis elegans model of Alzheimer's disease" @default.
• W4289939749 cites W1599486403 @default.
• W4289939749 cites W1981964968 @default.
• W4289939749 cites W1993376417 @default.
• W4289939749 cites W1999378798 @default.
• W4289939749 cites W2000576307 @default.
• W4289939749 cites W2013205631 @default.
• W4289939749 cites W2027353223 @default.
• W4289939749 cites W2038976773 @default.
• W4289939749 cites W2058942375 @default.
• W4289939749 cites W2074184688 @default.
• W4289939749 cites W2075066102 @default.
• W4289939749 cites W2116721571 @default.
• W4289939749 cites W2231558274 @default.
• W4289939749 cites W2236396134 @default.
• W4289939749 cites W2238802835 @default.
• W4289939749 cites W2312476219 @default.
• W4289939749 cites W2346080909 @default.
• W4289939749 cites W2496153702 @default.
• W4289939749 cites W2523197849 @default.
• W4289939749 cites W2536799296 @default.
• W4289939749 cites W2582102037 @default.
• W4289939749 cites W2888081881 @default.
• W4289939749 cites W2892775161 @default.
• W4289939749 cites W2922203379 @default.
• W4289939749 cites W2938534449 @default.
• W4289939749 cites W2944628830 @default.
• W4289939749 cites W2948860401 @default.
• W4289939749 cites W2957501625 @default.
• W4289939749 cites W2972655539 @default.
• W4289939749 cites W2984060329 @default.
• W4289939749 cites W3004728909 @default.
• W4289939749 cites W3014615892 @default.
• W4289939749 cites W3025624770 @default.
• W4289939749 cites W3154242771 @default.
• W4289939749 cites W3165494836 @default.
• W4289939749 cites W3215794336 @default.
• W4289939749 cites W4206451389 @default.
• W4289939749 doi "https://doi.org/10.3389/fnagi.2022.955113" @default.
• W4289939749 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35992601" @default.
• W4289939749 hasPublicationYear "2022" @default.
• W4289939749 type Work @default.
• W4289939749 citedByCount "3" @default.
• W4289939749 countsByYear W42899397492023 @default.
• W4289939749 crossrefType "journal-article" @default.
• W4289939749 hasAuthorship W4289939749A5002194502 @default.
• W4289939749 hasAuthorship W4289939749A5009923185 @default.
• W4289939749 hasAuthorship W4289939749A5015179224 @default.
• W4289939749 hasAuthorship W4289939749A5030633188 @default.
• W4289939749 hasAuthorship W4289939749A5032041646 @default.
• W4289939749 hasAuthorship W4289939749A5037431238 @default.
• W4289939749 hasBestOaLocation W42899397491 @default.
• W4289939749 hasConcept C102230213 @default.
• W4289939749 hasConcept C104317684 @default.
• W4289939749 hasConcept C126322002 @default.
• W4289939749 hasConcept C127561419 @default.
• W4289939749 hasConcept C134018914 @default.
• W4289939749 hasConcept C141035611 @default.
• W4289939749 hasConcept C170493617 @default.
• W4289939749 hasConcept C25498285 @default.
• W4289939749 hasConcept C2775838275 @default.
• W4289939749 hasConcept C2776151105 @default.
• W4289939749 hasConcept C2777633098 @default.
• W4289939749 hasConcept C2778938600 @default.
• W4289939749 hasConcept C2778944004 @default.
• W4289939749 hasConcept C29730261 @default.
• W4289939749 hasConcept C48349386 @default.
• W4289939749 hasConcept C55493867 @default.
• W4289939749 hasConcept C59822182 @default.
• W4289939749 hasConcept C71924100 @default.
• W4289939749 hasConcept C86803240 @default.
• W4289939749 hasConcept C95444343 @default.
• W4289939749 hasConcept C98274493 @default.
• W4289939749 hasConceptScore W4289939749C102230213 @default.
• W4289939749 hasConceptScore W4289939749C104317684 @default.
• W4289939749 hasConceptScore W4289939749C126322002 @default.
• W4289939749 hasConceptScore W4289939749C127561419 @default.
• W4289939749 hasConceptScore W4289939749C134018914 @default.
• W4289939749 hasConceptScore W4289939749C141035611 @default.
• W4289939749 hasConceptScore W4289939749C170493617 @default.
• W4289939749 hasConceptScore W4289939749C25498285 @default.
• W4289939749 hasConceptScore W4289939749C2775838275 @default.
• W4289939749 hasConceptScore W4289939749C2776151105 @default.
• W4289939749 hasConceptScore W4289939749C2777633098 @default.
• W4289939749 hasConceptScore W4289939749C2778938600 @default.
• W4289939749 hasConceptScore W4289939749C2778944004 @default.
• W4289939749 hasConceptScore W4289939749C29730261 @default.
• W4289939749 hasConceptScore W4289939749C48349386 @default.
• W4289939749 hasConceptScore W4289939749C55493867 @default.
• W4289939749 hasConceptScore W4289939749C59822182 @default.

• next